1.58
price down icon1.25%   -0.02
after-market Handel nachbörslich: 1.57 -0.01 -0.63%
loading

Finanzdaten der Geron Corp-Aktie (GERN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
1.67%
48.02
47.23 49.04 39.60 47.54
Operating Expenses
20.36%
73.56
61.11 61.49 56.31 67.59
Benefits Costs and Expenses
267.31
- - - 72.84
Costs And Expenses
20.36%
73.56
61.11 61.49 56.31 72.05
Depreciation and Amortization
32.03%
0.087
0.128 0.128 0.131 0.142
Operating Income/Loss
83.91%
-25.54
-13.89 -12.45 -16.70 -20.05
Income/Loss From Continuing Operations Before Tax
564.33%
-219.29
47.23 -16.38 -19.84 -25.30
Income/Loss From Continuing Operations After Tax
56.62%
-28.86
-18.43 -16.38 -19.84 -25.75
Net Income/Loss
56.62%
-28.86
-18.43 -16.38 -19.84 -25.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.96%
0.2661
667.10 666.17 665.91 6.0996
Diluted Average Shares
99.96%
0.2661
667.10 666.17 665.91 6.0996
Basic Earnings Per Share
66.67%
-0.05
-0.03 -0.02 -0.03 -0.04
Diluted Earnings Per Share
66.67%
-0.05
-0.03 -0.02 -0.03 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):